Neurogene Inc. (NASDAQ: NGNE)
$36.4200
-35.1000 ( -49.10% ) 823.0K
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
Market Data
Open
$36.4200
Previous close
$71.5300
Volume
823.0K
Market cap
$582.62M
Day range
$36.3150 - $49.5450
52 week range
$12.4900 - $74.4900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 62 | Nov 12, 2024 |
| 8-k | 8K-related | 19 | Nov 04, 2024 |
| 8-k | 8K-related | 53 | Aug 09, 2024 |
| 10-q | Quarterly Reports | 78 | Aug 09, 2024 |
| 8-k | 8K-related | 15 | Aug 07, 2024 |
| 8-k | 8K-related | 51 | Jun 21, 2024 |
| 8-k | 8K-related | 15 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |